Table 3.
Initial management and change in management
| Patient # | Inintial manangement | Change in management |
|---|---|---|
| 1 | None | Doxil, Cytoxan |
| 2 | None | Paclitaxel, Carboplatin, Tarceva |
| 3 | Temodar, Thalidomide | Docetaxel |
| 4 | None | Temodar |
| 5 | None | Chemotherapy |
| 6 | None | Chemotherapy |
| 7 | None | Docetaxil, Caroplatin |
| 8 | Pemetrexed, Carboplatin | Erlotinib |
| 9 | None | Folfiri, Avastin |
| 10 | None | Thyroidectomy, bilateral neck dissection |
| 11 | None | Emetrexed, Carboplatin |
| 12 | None | Arboplatin, Paclitaxel |
| 13 | None | Xeloda |
| 14 | None | Hospice |
| 15 | None | Carboplatin, Certuximab |
| 16 | None | Capecitabine, Ixabepilone |
| 17 | None | Carboplatin, Paclitaxel |
| 18 | Trastuzumb, Arimidex | Trastuzumab, radiation |
| 19 | None | Erbitux with Gemcitabine |
| 20 | None | Lost to follow-up |
| 21 | None | Taxotere, Cisplatin, Tarceva |
| 22 | Aarimidex | Ixabepilone, Bevacizumab |
| 23 | None | Pemetrexed, Carboplatin,Bevacizumab |
| 24 | None | Doxetaxel, Cisplatin |